Business Description
HealthEquity Inc
NAICS : 519190
SIC : 8099
ISIN : US42226A1079
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.28 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.54 | |||||
Debt-to-EBITDA | 3.37 | |||||
Interest Coverage | 3.29 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 4.08 | |||||
Beneish M-Score | -2.65 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.8 | |||||
3-Year EBITDA Growth Rate | 16.8 | |||||
3-Year EPS without NRI Growth Rate | 57.7 | |||||
3-Year FCF Growth Rate | 26.5 | |||||
3-Year Book Growth Rate | 9.8 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 24.35 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.96 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.87 | |||||
9-Day RSI | 57.97 | |||||
14-Day RSI | 59.6 | |||||
6-1 Month Momentum % | 5.78 | |||||
12-1 Month Momentum % | 29.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.1 | |||||
Quick Ratio | 4.1 | |||||
Cash Ratio | 2.7 | |||||
Days Sales Outstanding | 33.76 | |||||
Days Payable | 12.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.7 | |||||
Shareholder Yield % | -0.45 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 65.06 | |||||
Operating Margin % | 16.3 | |||||
Net Margin % | 9.61 | |||||
FCF Margin % | -18.01 | |||||
ROE % | 5.17 | |||||
ROA % | 3.28 | |||||
ROIC % | 5.11 | |||||
3-Year ROIIC % | -23.31 | |||||
ROC (Joel Greenblatt) % | 169.69 | |||||
ROCE % | 5.95 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 74.36 | |||||
Forward PE Ratio | 24.14 | |||||
PE Ratio without NRI | 36.55 | |||||
Shiller PE Ratio | 182.1 | |||||
Price-to-Owner-Earnings | 216.59 | |||||
PEG Ratio | 3.18 | |||||
PS Ratio | 6.96 | |||||
PB Ratio | 3.61 | |||||
Price-to-Operating-Cash-Flow | 24.9 | |||||
EV-to-EBIT | 45.5 | |||||
EV-to-Forward-EBIT | 32.33 | |||||
EV-to-EBITDA | 24.53 | |||||
EV-to-Revenue | 7.66 | |||||
EV-to-Forward-Revenue | 6.39 | |||||
EV-to-FCF | -42.56 | |||||
Price-to-Projected-FCF | 3.82 | |||||
Price-to-Median-PS-Value | 0.62 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.68 | |||||
Earnings Yield (Greenblatt) % | 2.2 | |||||
FCF Yield % | -2.54 | |||||
Forward Rate of Return (Yacktman) % | 13.86 |